EASE-SOT Pilot Study

NANot yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Transplant;Failure,KidneyTransplant; Failure, HeartTransplant; Failure, LiverTransplant; Failure, PancreasTransplant; Failure, Lung(S)
Interventions
OTHER

EASE-SOT

EASE integrates supportive counseling and trauma-focused cognitive behavioral therapy (CBT) (EASE-psy) with systematic physical symptom screening and triggered referral to supportive care to manage moderate to severe physical symptoms (EASE-phys) using electronic patient reported outcome measures (ePROMs). The intervention duration is 8 weeks. Based on individual preference, EASE-psy may be administered in person or virtually via Microsoft Teams. Based on individual preference, participants may receive ePROMs either on tablets or to their personal electronic devices via email, while at the hospital ward and in clinics, ensuring easy access and administration of these tools.

Trial Locations (1)

M5G2C4

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT06396702 - EASE-SOT Pilot Study | Biotech Hunter | Biotech Hunter